Kidney Beginnings - June 2021 |
|
We are happy to announce AAKP's 4th Annual Policy Summit, happening June 17, 2021!
The 4th Annual Policy Summit will continue to bring together key influencers from across all sectors of the policy spectrum – patients, healthcare professionals, researchers, industry, and the federal government.
The focus for 2021 will be to highlight innovation in kidney biologics, diagnostics, and devices as well as examine the expanding impact of kidney disease in America and the accelerating need for policies that honor full consumer choice in treatment and smarter policies to better align both regulatory and payment decisions.
Click here for more details, and register now for free by clicking on the button below!
|
Thank you to ALL who tuned in from across the world for the AAKP/GWU 3rd Annual Global Summit on kidney care. Medical experts said PATIENTS DRIVE INNOVATION!
If you missed it, you can watch all sessions now OnDemand!
Click on the button below to access all sessions.
|
UPCOMING WEBINAR
REGISTER NOW!
REGISTER NOW for AAKP's "Path to Diagnosis: Understanding Genetic Testing" webinar.
This webinar is made possible by an educational donation from Vertex Pharmaceuticals.
|
|
AAKP IMAGINES AND WORKS FOR CHANGE!
Do you know a living kidney donor that experienced discrimination/retaliation in life or disability insurance SIMPLY because they wanted to give the Gift of Life?
Tell us that story by clicking on the button below!
|
READ! New story from the National Journal: "Patient advocates plan for post-COVID Congress."
AAKP's Chair of Policy and Global Affairs Paul Conway quoted, explaining how AAKP has accommodated patient advocates during COVID-19.
|
Summer is almost here and the temperature is rising!
As the thermometer climbs, we often find ourselves reaching for a cold drink to cool off our bodies, when in fact there are better ways to cool off. Staying cool while limiting your fluids is especially difficult when you are living with Chronic Kidney Disease (CKD).
READ this AAKP blog post by McIlnay, MS, RDN, LD, for tips to help you manage your thirst and fluid intake while enjoying summer with your family and friends.
Click the button below to read the blog post.
|
Let our recipes and information about nutrition and
cooking inspire you.
Get ready to experience the joy of preparing and sharing kidney-friendly meals!
|
|
Scientists from the University of Granada (UGR), the Hospital Universitario La Paz (Madrid), and the University of Texas (USA) have taken an important step in the fight against kidney damage and its progression towards kidney failure, which is closely related to diabesity (obesity and its type 2 diabetes) and its complications.
Specifically, in two new studies recently published in the scientific journals "Journal of Clinical Medicine" and "Pharmaceuticals", researchers have developed it in an obese and diabetic rodent model, and have shown that melatonin protects the kidney damage caused by diabesity.
Scientists have shown that chronic administration of melatonin at doses (0 mg/kg body weight/day) prevents mitochondrial and endoplasmic reticulum disruption, which plays a critical role in the development and pathogenesis of kidney cell (nephron) damage, and its progression to renal failure.
According to the results indicated by these researchers, melatonin could help treat kidney damage, which establishes the need to develop new clinical trials to test its effectiveness in humans. The encouraging results obtained in preclinical models invite to take melatonin to the next phase, in order to investigate how it helps in the maintenance of mitochondrial and endoplasmic reticulum homeostasis, and to a greater extent, if melatonin therapy would allow delaying or stopping progressive renal damage, by promoting its chronic pharmacological use in kidney repair and regeneration.
Click the button below to read more.
|
|
Patients with chronic kidney disease (CKD) who take potentially inappropriate medications (PIMs) may increase their risks for falls, hospitalization, and death, a new study finds.
In an analysis of the Chronic Renal Insufficiency Cohort (CRIC) study including 3929 adults aged 21 to 74 years with CKD (approximately 20% with an estimated glomerular filtration rate of less than 30 mL/min/1.73 m2), 80% of patients had a history of taking 1 or more PIMs, Rasheeda Hall, MD, MBA, MHSc, of Duke University in Durham, North Carolina, and colleagues reported in the American Journal of Kidney Diseases.
“These findings suggest additional evidence is needed to guide prescribing of [potentially inappropriate medications] in the general adult CKD population regardless of age to both minimize adverse outcomes and optimally manage comorbid conditions,” according to Dr. Hall’s team. Deprescribing these drugs would be challenging, they wrote, so strategies such as reassessing need, discussing risks with patients, and medication tapering might be helpful.
Click the button below to read more about this study.
|
|
Researchers from the University of South Australia have found an enzyme that might help reduce chronic kidney disease cases. The enzyme NEDD4-2 is important for kidney health. The research found a correlation between a high salt diet, low levels of NEDD4-2, and advanced kidney disease, scientists shared in Cell Death & Disease.
“We now know that both a high sodium diet and low NEDD4-2 levels promote renal disease progression, even in the absence of high blood pressure, which normally goes hand in hand with increased sodium,” shared UniSA Centre for Cancer Biology scientist Dr. Jantina Manning.
The research helped identify the connection between the enzyme and salt, and the r esearchers now realize that NEDD4-2 played a role in salt-induced kidney function.
Click the button below to read more.
|
|
Follow and like AAKP on social media! |
Click on Update Profile below to change your
AAKP newsletter preferences.
AAKP newsletters are for informational purposes and share some of the latest news in popular media and within the kidney community. The content included is not necessarily the opinion of the Association.
AAKP has no control and is not liable for article links that have been removed/changed/broken.
|
|
|
|
|
|
|
